Study of how tafluprost is distributed in blood circulation after ocular administration in children who have glaucoma or elevated intraocular pressure. Tolerance to the drug and safety in general will also be assessed. Study of how tafluprostis distributed in blood circulation after ocular administration in children w ...
A phase I study to evaluate the pharmacokinetics, safety and tolerability of preservative free tafluprost ophthalmic solution (0.0015%) in pediatric patients diagnosed with glaucoma or ocular hypertension. - Phase I Study to Evaluate Tafluprost Eye Drops in Paediatric Patients. A phase I study to evaluate the pharmacokinetics, safety and tolerability of preservative free taflu ...
Glaucoma or Ocular Hypertension MedDRA version: 18.1;Level: PT;Classification code 10011762;Term: Cystic fibrosis;System Organ Class: 10010331 - Congenital, familial and genetic disorders;Therapeutic area: Diseases [C] - Eye Diseases [C11] Glaucoma or Ocular Hypertension MedDRA version: 18.1;Level: PT;Classification code 10011762;Term: Cy ...
Trade Name: Tafluprost INN or Proposed INN: tafluprost Other descriptive name: TAFLUPROST
Santen Oy
NULL
Not Recruiting
Female: yes Male: yes
18
Phase 1
United States;Hungary;Slovakia;Poland;United Kingdom
Study of how tafluprost is distributed in blood circulation after ocular administration in children who have glaucoma or elevated intraocular pressure. Tolerance to the drug and safety in general will also be assessed. Study of how tafluprostis distributed in blood circulation after ocular administration in children w ...
A phase I study to evaluate the pharmacokinetics, safety and tolerability of preservative free tafluprost ophthalmic solution (0.0015%) in pediatric patients diagnosed with glaucoma or ocular hypertension. - Phase I Study to Evaluate Tafluprost Eye Drops in Paediatric Patients. A phase I study to evaluate the pharmacokinetics, safety and tolerability of preservative free taflu ...
Glaucoma or Ocular Hypertension MedDRA version: 18.1;Level: PT;Classification code 10011762;Term: Cystic fibrosis;System Organ Class: 10010331 - Congenital, familial and genetic disorders;Therapeutic area: Diseases [C] - Eye Diseases [C11] Glaucoma or Ocular Hypertension MedDRA version: 18.1;Level: PT;Classification code 10011762;Term: Cy ...
Trade Name: Tafluprost INN or Proposed INN: tafluprost Other descriptive name: TAFLUPROST
Santen Oy
NULL
Not Recruiting
Female: yes Male: yes
18
Phase 1
United States;Hungary;Slovakia;Poland;United Kingdom
Study of how tafluprost is distributed in blood circulation after ocular administration in children who have glaucoma or elevated intraocular pressure. Tolerance to the drug and safety in general will also be assessed. Study of how tafluprostis distributed in blood circulation after ocular administration in children w ...
A phase I study to evaluate the pharmacokinetics, safety and tolerability of preservative free tafluprost ophthalmic solution (0.0015%) in pediatric patients diagnosed with glaucoma or ocular hypertension. - Phase I Study to Evaluate Tafluprost Eye Drops in Paediatric Patients. A phase I study to evaluate the pharmacokinetics, safety and tolerability of preservative free taflu ...